Email updates

Keep up to date with the latest news and content from Journal of Ovarian Research and BioMed Central.

Open Access Highly Accessed Review

Oocyte-granulosa-theca cell interactions during preantral follicular development

Makoto Orisaka1*, Kimihisa Tajima1, Benjamin K Tsang2345 and Fumikazu Kotsuji1

Author Affiliations

1 Department of Obstetrics & Gynecology, University of Fukui, Matsuoka, Fukui, 910-1193, Japan

2 Reproductive Biology Unit and Division of Reproductive Medicine, Department of Obstetrics, University of Ottawa, Ontario, Canada

3 Gynaecology and Cellular & Molecular Medicine, University of Ottawa, Ontario, Canada

4 Chronic Disease Program, Ottawa Hospital Research Institute, The Ottawa Hospital (Civic Campus), Ottawa, Ontario, K1Y 4E9, Canada

5 World Class University Major in Biomodulation, Department of Agricultural Biotechnology, College of Agriculture and Life Sciences, Seoul National University, South Seoul 151-921, South Korea

For all author emails, please log on.

Journal of Ovarian Research 2009, 2:9  doi:10.1186/1757-2215-2-9

The electronic version of this article is the complete one and can be found online at:

Received:27 May 2009
Accepted:9 July 2009
Published:9 July 2009

© 2009 Orisaka et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The preantral-early antral follicle transition is the penultimate stage of follicular development in terms of gonadotropin dependence and follicle destiny (growth versus atresia). Follicular growth during this period is tightly regulated by oocyte-granulosa-theca cell interactions. Formation of the theca cell layer is a key event that occurs during this transitional stage. Granulosal factor(s) stimulates the recruitment of theca cells from cortical stromal cells, while oocyte-derived growth differentiation factor-9 (GDF-9) is involved in the differentiation of theca cells during this early stage of follicular development. The preantral to early antral transition is most susceptible to follicular atresia. GDF-9 promotes follicular survival and growth during transition from preantral stage to early antral stage by suppressing granulosa cell apoptosis and follicular atresia. GDF-9 also enhances preantral follicle growth by up-regulating theca cell androgen production. Thecal factor(s) promotes granulosa cell proliferation and suppress granulosa cell apoptosis. Understanding the intraovarian mechanisms in the regulation of follicular growth and atresia during this stage may be of clinical significance in the selection of the best quality germ cells for assisted reproduction. In addition, since certain ovarian dysfunctions, such as polycystic ovarian syndrome and gonadotropin poor-responsiveness, are consequences of dysregulated follicle growth at this transitional stage, understanding the molecular and cellular mechanisms in the control of follicular development during the preantral-early antral transition may provide important insight into the pathophysiology and rational treatment of these conditions.


The ovarian follicle, consisting of an oocyte surrounded by granulosa and theca cells, represents the basic functional unit of the ovary. Follicular growth can be classified into three phases according to their developmental stage and gonadotropin dependence [1-3] (Fig. 1): (1) follicular growth through primordial, primary, and secondary stages (gonadotropin-independent phase), (2) transition from preantral to early antral stage (gonadotropin-responsive phase), and (3) continual growth beyond the early antral stage (gonadotropin-dependent phase), which includes follicle recruitment, selection, and ovulation [4]. In the second (gonadotropin-responsive) phase, growth of the follicles is primarily controlled by intraovarian regulators (e.g., growth factors, cytokines, and gonadal steroids) and does not require gonadotropins for growth [5,6], although it is also stimulated by the presence of FSH [1,7,8].

thumbnailFigure 1. The transition of the follicle from the preantral to early antral stage is the "penultimate" stage of development in terms of gonadotropin (Gn) dependence and follicle destiny (growth versus atresia).

The transition of the follicle from the preantral to early antral stage is the "penultimate" stage of development in terms of gonadotropin dependence and follicle destiny (growth versus atresia) [9] (Fig. 1). Follicles selected for further development are thought to receive precise gonadotropic and intra-ovarian regulatory signals for survival, whereas follicular atresia is a consequence of inadequate growth support [10]. As the preantral-early antral transition is most susceptible to follicular atresia [1,11], understanding the intraovarian mechanisms in the regulation of follicular growth and atresia during this stage may be of clinical significance in providing germ cells for assisted reproduction. Since ovarian dysfunctions, such as polycystic ovarian syndrome (PCOS) and gonadotropin poor-responsiveness, are consequences of this transitional stage-specific dysregulated follicle growth [3], understanding the molecular and cellular mechanisms in the control of follicular development during the preantral-early antral transition may provide important insight into the pathophysiology of these conditions. This review will focus on recent progress that has been made in understanding the importance of intraovarian cell-cell interactions during follicular development from preantral to early antral stage.

Formation of the theca cell layer

The role of theca cells in follicular function has received less attention compared with intensive investigation into the role of granulosa cells [12]. Nevertheless, the appearance of a theca cell layer at the preantral stage is an important physiological event for early follicular development, as evidenced by: 1) the concurrence of the organization of the theca cell layer and the increased follicular growth and steroidogenic response to gonadotropins [13,14]; 2) increased structural support by the theca cell layer and blood supply containing ovarian regulators for the developing follicle [15,16]; and 3) increased thecal aromatizable androgen production for granulosa cell estrogen biosynthesis and enhanced early follicular growth by androgenic products of the theca cell [17-21].

Granulosa-stromal (pretheca) cell interaction

The origin of theca cells has been a long-standing research interest and whether the cortical or medullary stromal cells are thecal stem cells remains an unanswered question. Our recent studies with a bovine co-culture model [22,23] indicates that cortical but not medullary stromal cells are actively transformed into theca cells by the presence of granulosa cells, a process associated with increased LH receptor (LHR) mRNA expression and androstenedione production [24]. These findings suggest that granulosa cells play a decisive role in the differentiation of cortical stromal cells into LH-responsive steroidogenically active theca cells by the secretion and action of a soluble factor(s). In support of this theory, an array of paracrine factors from granulosa cells governing theca cell differentiation have been reported in humans [25]. Huang et al. reported that the combination of two granulosa cell-produced peptides, i.e. insulin-like growth factor-I (IGF-I) and kit ligand (KL), increased gene expression for androgenic factors and androgen production in rat theca-interstitial cells [26]. Using the bovine ovarian organ culture model, Parrott and Skinner also reported that KL stimulated ovarian stromal cell proliferation, whereas it had no effect on androgen production [27]. Theca cells maintain epithelial-like appearance and androgenic capacity when co-cultured with granulosa cells, but become fibroblastic and produce less androgen when cultured alone [22], suggesting that the presence of granulosal factor(s) is indispensable for theca cells to sustain their morphology and function.

Oocyte-theca cell interaction

Oocyte-somatic cell interaction plays a critical role in folliculogenesis, including activation of resting follicles, early growth, and terminal differentiation [28-31]. Growth differentiation factor-9 (GDF-9) is an oocyte-derived factor and a member of the TGF-β superfamily, which includes TGF-β, activin, and bone morphogenetic proteins (BMPs) [32,33]. Ovaries from GDF-9 null mice exhibit a developmental block at the primary follicle stage, which is characterized by failed theca cell layer formation in early follicles [34]. These observations raise the possibility that GDF-9 also stimulates theca cell recruitment, proliferation and differentiation, and induces the formation of theca cell layer during this early stage of the follicular development. Nevertheless, GDF-9 is believed to be more important for the differentiation than the recruitment of theca cells, since the double-mutant (GDF-9 and inhibin α) mouse exhibits preantral follicles with theca cells having typical morphology but undetectable selective thecal markers, CYP17A1 and LH receptor [35]. GDF-9 treatment increases androgen production in cultured rat theca-interstitial cells [36] and promotes murine ovarian expression of the specific theca cell marker CYP17A1 [34]. GDF-9 increases theca cell number and DNA synthesis in theca cells of small bovine follicles [37]. We recently indicated that GDF-9 augments androgen production and CYP17A1 mRNA expression in rat preantral follicles, whereas down-regulation of GDF-9 by intra-oocyte injection of GDF-9 Morpholino antisense oligos suppressed these responses, indicating that GDF-9 is important in theca cell differentiation during preantral-early antral transition [38].

Follicular growth and atresia during the preantral-early antral transition

In mammals, a single or small number of germ cell(s) will ovulate during an ovarian cycle, whereas most follicles undergo atresia by follicle cell apoptosis [1,3,15], a selection process that ensures the release of only the healthiest and most viable oocytes [39,40]. Cell apoptosis is triggered by activation of a series of cysteine aspartate-specific proteases (caspases), which include initiator caspases (e.g. caspase-8 and -9) and effector caspases (e.g. caspase-3). Although apoptosis can occur at all stages of follicular development, the early antral follicles (diameter: 200–400 μm in rats, 2–5 mm in human) are most susceptible to atreatogenic signals [1,11,41]. In contrast, minimal atresia or granulosa cell apoptosis is evident in preantral and the smallest antral follicles (diameter: <200 μm in rats, <2 mm in human) [15,42]. Accordingly, the preantral to early antral transition is the penultimate stage of development in terms of gonadotropin dependence and follicle destiny (survival/growth vs. atresia) [9]. Follicular growth and atresia during this transitional stage is mainly regulated by intrafollicular regulators, such as growth factors, cytokines, and steroids.

Oocyte-granulosa cell interaction

Deletion of GDF-9 in the oocyte results in decreased granulosa cell proliferation, abnormal oocyte growth, and failure of follicles to develop past the primary stage [43], demonstrating the importance of this growth factor in early follicular development. GDF-9 stimulates rat granulosa cell proliferation, cumulus cell expansion, and preantral follicle growth in vitro [44]. We have recently demonstrated that GDF-9 down-regulation attenuates both basal and FSH-induced follicular growth in vitro, while the addition of recombinant GDF-9 enhances basal and FSH-induced follicular growth in rat [9]. In addition, down-regulation of GDF-9 content increases caspase-3 activation and granulosa cell apoptosis [9]. GDF-9 was sufficient to suppress ceramide-induced apoptosis in primary granulosa cells from early antral, but not large/preovulatory follicles [9], suggesting that GDF-9 is an important granulosa cell survival factor during the preantral to early antral transition, but may play a lesser role in follicle survival past antrum formation. GDF-9 also promotes development and survival of human early follicles in organ culture [45]. There may be considerable crosstalk between GDF-9 and FSH during the preantral-early antral transition, as GDF-9 is required to maintain FSH receptor expression in the preantral follicles [9], and GDF-9 receptors (BMPRII and ALK-5) are up-regulated by co-treatment of estrogen and FSH [46]. Although bone morphogenic protein-15 (BMP-15), another oocyte-specific member of the TGF-β superfamily, is also an important regulator of ovarian function [33], whether its action in granulosa cells is anti-apoptotic during this transitional stage and important in protecting the preantral follicles from undergoing atresia remains unknown.

Oocyte-theca cell interaction

Ovarian androgens are produced by theca cells, and act via receptors (AR) localized to granulosa cells, stromal cells, and oocytes [47]. Inactivation of AR in female mice results in premature ovarian failure, indicating that normal folliculogenesis requires AR-mediated androgen action [48,49]. AR expression is highest in granulosa cells of rat small preantral and early antral follicles [50], raising the possibility that androgens are important paracrine regulators of follicular growth during preantral to early antral transition. Although androgens have long been implicated as an inhibitor of antral follicular development [51,52], recent evidence suggests that the effect of androgens on follicular growth is dependent on the stage of follicular development and that androgens also have a growth promoting role in early folliculogenesis. Administration of androgens to adult rhesus monkeys significantly increased the number of preantral and small antral follicles as well as granulosa and theca cell proliferation [17]. In vitro studies have shown that androgens stimulate preantral follicle growth and granulosa cell mitosis in mice [19], the transition of primary follicles to secondary follicles in cattle [53], and follicular survival in human [54].

We have recently shown that oocyte-derived GDF-9 enhances rat preantral follicle growth, and augments androgen production and CYP17A1 mRNA expression in the preantral follicles, whereas down-regulation of GDF-9 suppressed these responses [38]. The specific AR antagonist flutamide suppressed GDF-9-induced preantral follicle growth in vitro [38]. The non-aromatizable androgen DHT, but not estradiol, rescued the follicular growth arrest by GDF-9 down-regulation [38], indicating that androgens exert a direct stimulatory action on the follicular development, especially during the preantral-early antral stage transition. These results suggest that GDF-9 promotes rat preantral follicle growth by up-regulating theca cell androgen production.

Theca-granulosa cell interaction

Evidence indicates that steroidal and nonsteroidal factors produced by granulosa and theca cells influence proliferation and differentiation of both cell types on opposite sides of a basement membrane during folliculogenesis [1,7,15,55-58]. LH receptors are found exclusively on theca cells and FSH receptors exclusively on granulosa cells during preantral follicle development. LH stimulates theca cell androgen and growth factor production, while FSH induces aromatase expression and increases the conversion of theca cell androgen to estrogen (two-cell two-gonadotropin theory [59]). Although growth beyond the small antral follicle is characterized by increased aromatase activity and follicular estrogen production, the aromatase activity before the small antral stage is limited [47], suggesting that androgen plays a more important role than estrogen during the preantral to early antral transition. It has been reported that androgens stimulate preantral follicle growth and granulosa cell mitosis [17,19]. Androgens also enhance FSH action in the follicles by increasing FSH receptor expression, FSH-induced granulosa cell aromatase activity and proliferation, and follicular growth [18,47,60,61]. Although we have shown that GDF-9 is required for the expression of FSH receptor in rat preantral follicles [9], whether this response is modulated through thecal androgen actions awaits further investigation. Although it has been demonstrated that LH stimulates follicular maturation [62,63] and induces follicular atresia [64], recent studies suggest that LH is also a stimulant for early stages of follicular growth [12,65,66].

Our previous studies suggest that theca cell-derived soluble growth factors promote granulosa cell proliferation [22] and suppress granulosa cell apoptosis [12] in early, but not large, antral follicles. Although the nature of the theca-granulosa cell interaction remains to be determined, recent studies also suggest the importance of this interaction in the regulation of apoptosis of granulosa cells. Epidermal growth factor (EGF), TGF-α, keratinocyte growth factor (KGF), hepatocyte growth factor (HGF), and BMP-7 appear to be potential physiological inhibitors of apoptotic cell death in the ovary [27,67-71]. These growth factors produced by theca cells might be one of the factors that decreased the incidence of apoptosis in granulosa cells during the preantral/early antral transition.


The preantral to early antral transition is the penultimate stage of follicular development in terms of gonadotropin dependence and follicle destiny (growth versus atresia). Follicular growth during the preantral-early antral transition is tightly regulated by intra-ovarian oocyte-granulosa-theca cell interactions (Fig. 2). Formation of the theca cell layer is a key event that occurs during this transitional stage. Granulosal factor(s) appears to stimulate the recruitment of theca cells from cortical stromal cells, while oocyte-derived GDF-9 is involved in the differentiation of theca cells during this early stage of follicular development. The preantral to early antral transition is most susceptible to atreatogenic factors. GDF-9 also promotes follicular survival and growth during the preantral to early antral transition by suppressing granulosa cell apoptosis and follicular atresia. GDF-9 enhances preantral follicle growth by up-regulating theca cell androgen production. Thecal factor(s) also promote granulosa cell proliferation and suppress granulosa cell apoptosis. The challenge ahead is not only understand the precise nature of these interactions, but also how they interact in the regulation of follicle destiny, and how dysregulation in these interactions may lead to ovarian pathology such as PCOS and gonadotropin poor-responsiveness. In addition, identification of the factor(s) that promote follicle growth from the preantral stage to small antral stage may provide important information for the identification of intra-follicular biomarkers for the selection of healthy oocytes and embryos in assisted reproduction.

thumbnailFigure 2. Follicular growth during the preantral/early antral transition is tightly regulated by intra-ovarian oocyte-granulosa-theca cell interactions.


GDF-9: growth differentiation factor-9; PCOS: polycystic ovarian syndrome; LHR: LH receptor; IGF-I: insulin-like growth factor-I; KL: kit ligand; TGF-β: transforming growth factor-β; CYP17A1: 17α-hydroxylase/17,20 lyase; caspases: cysteine aspartate-specific proteases; BMP-15: Bone morphogenetic protein-15; ALK-5: activin-like receptor kinase-5; BMPRII: BMP receptor type II; AR: androgen receptor; DHT: 5α-dihydrotestosterone; EGF: epidermal growth factor; KGF: keratinocyte growth factor: HGF: hepatocyte growth factor; GC: granulosa cell; TC: theca cell; SC: stromal cell; FSHR: FSH receptor.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

MO and KT participated in drafting the full manuscript and creating figures. BKT and FK participated in substantial contribution to conception and revising it critically for important intellectual content. All authors read and approved the final manuscript.


This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT; Grant 19591892 and 21592093 to M.O.). This work was also supported by grants from the Canadian Institutes of Health Research (CIHR; MOP-10369 to B.K.T.) and the University of Ottawa International Creative Research Initiatives (Grant 100146 to B.K.T.) and was a part of the Program on Oocyte Health funded under the Healthy Gametes and Great Embryos Strategic Initiative of CIHR Institute of Human Development, Child and Youth Health (Grant HGG62293 to B.K.T.).


  1. McGee EA, Hsueh AJ: Initial and cyclic recruitment of ovarian follicles.

    Endocr Rev 2000, 21:200-14. PubMed Abstract | Publisher Full Text OpenURL

  2. McNatty KP, Reader K, Smith P, Heath DA, Juengel JL: Control of ovarian follicular development to the gonadotrophin-dependent phase: a 2006 perspective.

    Soc Reprod Fertil Suppl 2007, 64:55-68. PubMed Abstract OpenURL

  3. Craig J, Orisaka M, Wang H, Orisaka S, Thompson W, Zhu C, Kotsuji F, Tsang BK: Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death.

    Front Biosci 2007, 12:3628-39. PubMed Abstract | Publisher Full Text OpenURL

  4. Kumar TR, Wang Y, Lu N, Matzuk MM: Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.

    Nat Genet 1997, 15:201-4. PubMed Abstract | Publisher Full Text OpenURL

  5. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G: Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism.

    Nature 1977, 269:338-40. PubMed Abstract OpenURL

  6. Halpin DM, Charlton HM, Faddy MJ: Effects of gonadotrophin deficiency on follicular development in hypogonadal (hpg) mice.

    J Reprod Fertil 1986, 78:119-25. PubMed Abstract | Publisher Full Text OpenURL

  7. Richards JS: Perspective: the ovarian follicle – a perspective in 2001.

    Endocrinology 2001, 142:2184-93. PubMed Abstract | Publisher Full Text OpenURL

  8. Fortune JE: The early stages of follicular development: activation of primordial follicles and growth of preantral follicles.

    Anim Reprod Sci 2003, 78:135-63. PubMed Abstract | Publisher Full Text OpenURL

  9. Orisaka M, Orisaka S, Jiang JY, Craig J, Wang Y, Kotsuji F, Tsang BK: Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage.

    Mol Endocrinol 2006, 20:2456-68. PubMed Abstract | Publisher Full Text OpenURL

  10. Hu CL, Cowan RG, Harman RM, Quirk SM: Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells.

    Mol Endocrinol 2004, 18:326-38. PubMed Abstract | Publisher Full Text OpenURL

  11. Hirshfield AN: Development of follicles in the mammalian ovary.

    Int Rev Cytol 1991, 124:43-101. PubMed Abstract OpenURL

  12. Tajima K, Orisaka M, Mori T, Kotsuji F: Ovarian theca cells in follicular function.

    Reprod Biomed Online 2007, 15:591-609. PubMed Abstract | Publisher Full Text OpenURL

  13. Wandji SA, Srsen V, Voss AK, Eppig JJ, Fortune JE: Initiation in vitro of growth of bovine primordial follicles.

    Biol Reprod 1996, 55:942-8. PubMed Abstract | Publisher Full Text OpenURL

  14. Gutierrez CG, Ralph JH, Telfer EE, Wilmut I, Webb R: Growth and antrum formation of bovine preantral follicles in long-term culture in vitro.

    Biol Reprod 2000, 62:1322-8. PubMed Abstract | Publisher Full Text OpenURL

  15. Gougeon A: Regulation of ovarian follicular development in primates: facts and hypotheses.

    Endocr Rev 1996, 17:121-55. PubMed Abstract | Publisher Full Text OpenURL

  16. Braw-Tal R, Yossefi S: Studies in vivo and in vitro on the initiation of follicle growth in the bovine ovary.

    J Reprod Fertil 1997, 109:165-71. PubMed Abstract | Publisher Full Text OpenURL

  17. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA: Androgens stimulate early stages of follicular growth in the primate ovary.

    J Clin Invest 1998, 101:2622-9. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  18. Weil S, Vendola K, Zhou J, Bondy CA: Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

    J Clin Endocrinol Metab 1999, 84:2951-6. PubMed Abstract | Publisher Full Text OpenURL

  19. Murray AA, Gosden RG, Allison V, Spears N: Effect of androgens on the development of mouse follicles growing in vitro.

    J Reprod Fertil 1998, 113:27-33. PubMed Abstract | Publisher Full Text OpenURL

  20. Spears N, Murray AA, Allison V, Boland NI, Gosden RG: Role of gonadotrophins and ovarian steroids in the development of mouse follicles in vitro.

    J Reprod Fertil 1998, 113:19-26. PubMed Abstract | Publisher Full Text OpenURL

  21. Wang H, Andoh K, Hagiwara H, Xiaowei L, Kikuchi N, Abe Y, Yamada K, Fatima R, Mizunuma H: Effect of adrenal and ovarian androgens on type 4 follicles unresponsive to FSH in immature mice.

    Endocrinology 2001, 142:4930-6. PubMed Abstract | Publisher Full Text OpenURL

  22. Kotsuji F, Kamitani N, Goto K, Tominaga T: Bovine theca and granulosa cell interactions modulate their growth, morphology, and function.

    Biol Reprod 1990, 43:726-32. PubMed Abstract | Publisher Full Text OpenURL

  23. Orisaka M, Mizutani T, Tajima K, Orisaka S, Shukunami K, Miyamoto K, Kotsuji F: Effects of ovarian theca cells on granulosa cell differentiation during gonadotropin-independent follicular growth in cattle.

    Mol Reprod Dev 2006, 73:737-44. PubMed Abstract | Publisher Full Text OpenURL

  24. Orisaka M, Tajima K, Mizutani T, Miyamoto K, Tsang BK, Fukuda S, Yoshida Y, Kotsuji F: Granulosa cells promote differentiation of cortical stromal cells into theca cells in the bovine ovary.

    Biol Reprod 2006, 75:734-40. PubMed Abstract | Publisher Full Text OpenURL

  25. Magoffin DA, ed: The role of the ovary in the genesis of hyperandrogenism. 2nd edition. San Diego: Elsevier Academic Press; 2004.

  26. Huang CT, Weitsman SR, Dykes BN, Magoffin DA: Stem cell factor and insulin-like growth factor-I stimulate luteinizing hormone-independent differentiation of rat ovarian theca cells.

    Biol Reprod 2001, 64:451-6. PubMed Abstract | Publisher Full Text OpenURL

  27. Parrott JA, Skinner MK: Kit ligand actions on ovarian stromal cells: effects on theca cell recruitment and steroid production.

    Mol Reprod Dev 2000, 55:55-64. PubMed Abstract | Publisher Full Text OpenURL

  28. Eppig JJ, Wigglesworth K, Pendola FL: The mammalian oocyte orchestrates the rate of ovarian follicular development.

    Proc Natl Acad Sci USA 2002, 99:2890-4. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  29. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ: Intercellular communication in the mammalian ovary: oocytes carry the conversation.

    Science 2002, 296:2178-80. PubMed Abstract | Publisher Full Text OpenURL

  30. Vanderhyden BC, Caron PJ, Buccione R, Eppig JJ: Developmental pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and the role of oocytes in promoting granulosa cell differentiation.

    Dev Biol 1990, 140:307-17. PubMed Abstract | Publisher Full Text OpenURL

  31. Vanderhyden BC, Telfer EE, Eppig JJ: Mouse oocytes promote proliferation of granulosa cells from preantral and antral follicles in vitro.

    Biol Reprod 1992, 46:1196-204. PubMed Abstract | Publisher Full Text OpenURL

  32. Chang H, Brown CW, Matzuk MM: Genetic analysis of the mammalian transforming growth factor-beta superfamily.

    Endocr Rev 2002, 23:787-823. PubMed Abstract | Publisher Full Text OpenURL

  33. Shimasaki S, Moore RK, Otsuka F, Erickson GF: The bone morphogenetic protein system in mammalian reproduction.

    Endocr Rev 2004, 25:72-101. PubMed Abstract | Publisher Full Text OpenURL

  34. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM: Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary.

    Mol Endocrinol 1999, 13:1018-34. PubMed Abstract | Publisher Full Text OpenURL

  35. Wu X, Chen L, Brown CA, Yan C, Matzuk MM: Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice.

    Mol Endocrinol 2004, 18:1509-19. PubMed Abstract | Publisher Full Text OpenURL

  36. Solovyeva EV, Hayashi M, Margi K, Barkats C, Klein C, Amsterdam A, Hsueh AJ, Tsafriri A: Growth differentiation factor-9 stimulates rat theca-interstitial cell androgen biosynthesis.

    Biol Reprod 2000, 63:1214-8. PubMed Abstract | Publisher Full Text OpenURL

  37. Spicer LJ, Aad PY, Allen DT, Mazerbourg S, Payne AH, Hsueh AJ: Growth differentiation factor 9 (GDF9) stimulates proliferation and inhibits steroidogenesis by bovine theca cells: influence of follicle size on responses to GDF9.

    Biol Reprod 2008, 78:243-53. PubMed Abstract | Publisher Full Text OpenURL

  38. Orisaka M, Jiang JY, Orisaka S, Kotsuji F, Tsang BK: Growth differentiation factor 9 promotes rat preantral follicle growth by up-regulating follicular androgen biosynthesis.

    Endocrinology 2009, 150:2740-8. PubMed Abstract | Publisher Full Text OpenURL

  39. Johnson AL: Intracellular mechanisms regulating cell survival in ovarian follicles.

    Anim Reprod Sci 2003, 78:185-201. PubMed Abstract | Publisher Full Text OpenURL

  40. Hussein MR: Apoptosis in the ovary: molecular mechanisms.

    Hum Reprod Update 2005, 11:162-77. PubMed Abstract | Publisher Full Text OpenURL

  41. Boone DL, Carnegie JA, Rippstein PU, Tsang BK: Induction of apoptosis in equine chorionic gonadotropin (eCG)-primed rat ovaries by anti-eCG antibody.

    Biol Reprod 1997, 57:420-7. PubMed Abstract | Publisher Full Text OpenURL

  42. Hirshfield AN: Size-frequency analysis of atresia in cycling rats.

    Biol Reprod 1988, 38:1181-8. PubMed Abstract | Publisher Full Text OpenURL

  43. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM: Growth differentiation factor-9 is required during early ovarian folliculogenesis.

    Nature 1996, 383:531-5. PubMed Abstract | Publisher Full Text OpenURL

  44. Hayashi M, McGee EA, Min G, Klein C, Rose UM, van Duin M, Hsueh AJ: Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles.

    Endocrinology 1999, 140:1236-44. PubMed Abstract | Publisher Full Text OpenURL

  45. Hreinsson JG, Scott JE, Rasmussen C, Swahn ML, Hsueh AJ, Hovatta O: Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture.

    J Clin Endocrinol Metab. 2002, 87(1):316-321. PubMed Abstract | Publisher Full Text OpenURL

  46. Jayawardana BC, Shimizu T, Nishimoto H, Kaneko E, Tetsuka M, Miyamoto A: Hormonal regulation of expression of growth differentiation factor-9 receptor type I and II genes in the bovine ovarian follicle.

    Reproduction 2006, 131:545-53. PubMed Abstract | Publisher Full Text OpenURL

  47. Drummond AE: The role of steroids in follicular growth.

    Reprod Biol Endocrinol 2006, 4:16. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  48. Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C: Subfertility and defective folliculogenesis in female mice lacking androgen receptor.

    Proc Natl Acad Sci USA 2004, 101:11209-14. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  49. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, Sakari M, Takada I, Nakamura T, Metzger D, Chambon P, Kanno J, Yoshikawa H, Kato S: Premature ovarian failure in androgen receptor-deficient mice.

    Proc Natl Acad Sci USA 2006, 103:224-9. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  50. Tetsuka M, Whitelaw PF, Bremner WJ, Millar MR, Smyth CD, Hillier SG: Developmental regulation of androgen receptor in rat ovary.

    J Endocrinol 1995, 145:535-43. PubMed Abstract | Publisher Full Text OpenURL

  51. Bagnell CA, Mills TM, Costoff A, Mahesh VB: A model for the study of androgen effects on follicular atresia and ovulation.

    Biol Reprod 1982, 27:903-14. PubMed Abstract | Publisher Full Text OpenURL

  52. Billig H, Furuta I, Hsueh AJ: Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis.

    Endocrinology 1993, 133:2204-12. PubMed Abstract | Publisher Full Text OpenURL

  53. Yang MY, Fortune JE: Testosterone stimulates the primary to secondary follicle transition in bovine follicles in vitro.

    Biol Reprod 2006, 75:924-32. PubMed Abstract | Publisher Full Text OpenURL

  54. Otala M, Makinen S, Tuuri T, Sjoberg J, Pentikainen V, Matikainen T, Dunkel L: Effects of testosterone, dihydrotestosterone, and 17beta-estradiol on human ovarian tissue survival in culture.

    Fertil Steril 2004, 82(Suppl 3):1077-85. PubMed Abstract | Publisher Full Text OpenURL

  55. Driancourt MA, Reynaud K, Cortvrindt R, Smitz J: Roles of KIT and KIT LIGAND in ovarian function.

    Rev Reprod 2000, 5:143-52. PubMed Abstract | Publisher Full Text OpenURL

  56. Nilsson E, Skinner MK: Cellular interactions that control primordial follicle development and folliculogenesis.

    J Soc Gynecol Investig 2001, 8:S17-20. PubMed Abstract | Publisher Full Text OpenURL

  57. Vitt UA, Hsueh AJ: Stage-dependent role of growth differentiation factor-9 in ovarian follicle development.

    Mol Cell Endocrinol 2001, 183:171-7. PubMed Abstract | Publisher Full Text OpenURL

  58. Monget P, Fabre S, Mulsant P, Lecerf F, Elsen JM, Mazerbourg S, Pisselet C, Monniaux D: Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals.

    Domest Anim Endocrinol 2002, 23:139-54. PubMed Abstract | Publisher Full Text OpenURL

  59. Hillier SG, van den Boogaard AM, Reichert LE Jr, van Hall EV: Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro.

    J Clin Endocrinol Metab 1980, 50:640-7. PubMed Abstract | Publisher Full Text OpenURL

  60. Cardenas H, Herrick JR, Pope WF: Increased ovulation rate in gilts treated with dihydrotestosterone.

    Reproduction 2002, 123:527-33. PubMed Abstract | Publisher Full Text OpenURL

  61. Hickey TE, Marrocco DL, Gilchrist RB, Norman RJ, Armstrong DT: Interactions between androgen and growth factors in granulosa cell subtypes of porcine antral follicles.

    Biol Reprod 2004, 71:45-52. PubMed Abstract | Publisher Full Text OpenURL

  62. Pakarainen T, Zhang FP, Nurmi L, Poutanen M, Huhtaniemi I: Knockout of luteinizing hormone receptor abolishes the effects of follicle-stimulating hormone on preovulatory maturation and ovulation of mouse graafian follicles.

    Mol Endocrinol 2005, 19:2591-602. PubMed Abstract | Publisher Full Text OpenURL

  63. Mihm M, Baker PJ, Ireland JL, Smith GW, Coussens PM, Evans AC, Ireland JJ: Molecular evidence that growth of dominant follicles involves a reduction in follicle-stimulating hormone dependence and an increase in luteinizing hormone dependence in cattle.

    Biol Reprod 2006, 74:1051-9. PubMed Abstract | Publisher Full Text OpenURL

  64. Balasch J, Fabregues F: LH in the follicular phase: neither too high nor too low.

    Reprod Biomed Online 2006, 12:406-15. PubMed Abstract | Publisher Full Text OpenURL

  65. Sato C, Shimada M, Mori T, Kumasako Y, Otsu E, Watanabe H, Utsunomiya T: Assessment of human oocyte developmental competence by cumulus cell morphology and circulating hormone profile.

    Reprod Biomed Online 2007, 14:49-56. PubMed Abstract | Publisher Full Text OpenURL

  66. Mori T, Nonoguchi K, Watanabe H, Ishikawa H, Tamura I, Kinoshita K: Morphogenesis of polycystic ovaries as assessed by pituitary-ovarian androgenic function.

    Reprod Biomed Online 2009, 18:635-43. PubMed Abstract | Publisher Full Text OpenURL

  67. Hsueh AJ, Billig H, Tsafriri A: Ovarian follicle atresia: a hormonally controlled apoptotic process.

    Endocr Rev 1994, 15:707-24. PubMed Abstract | Publisher Full Text OpenURL

  68. Tilly JL, Billig H, Kowalski KI, Hsueh AJ: Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism.

    Mol Endocrinol 1992, 6:1942-50. PubMed Abstract | Publisher Full Text OpenURL

  69. McGee EA, Chun SY, Lai S, He Y, Hsueh AJ: Keratinocyte growth factor promotes the survival, growth, and differentiation of preantral ovarian follicles.

    Fertil Steril 1999, 71:732-8. PubMed Abstract | Publisher Full Text OpenURL

  70. Lee WS, Otsuka F, Moore RK, Shimasaki S: Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat.

    Biol Reprod 2001, 65:994-9. PubMed Abstract | Publisher Full Text OpenURL

  71. Wang Y, Asselin E, Tsang BK: Involvement of transforming growth factor alpha in the regulation of rat ovarian X-linked inhibitor of apoptosis protein expression and follicular growth by follicle-stimulating hormone.

    Biol Reprod 2002, 66:1672-80. PubMed Abstract | Publisher Full Text OpenURL